Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism
Hongyang Fan,Xiaojia Tang,YuXia Song,Peipei Liu,Yingzhu Chen
DOI: https://doi.org/10.2147/NDT.S251173
IF: 2.989
2020-05-29
Neuropsychiatric Disease and Treatment
Abstract:Hongyang Fan, 1, 2, * Xiaojia Tang, 2, 3, * Yuxia Song, 2, 3, * Peipei Liu, 1, 2 Yingzhu Chen 1, 2 1 Clinical Medical College, Yangzhou University, Yangzhou City, Jiangsu Province, People's Republic of China; 2 Department of Neurology, Northern Jiangsu Province Hospital, Yangzhou City, Jiangsu Province, People's Republic of China; 3 Department of Neurology, Clinical Medical College of Yangzhou, Dalian Medical University, Yangzhou City, Jiangsu Province, People's Republic of China *These authors contributed equally to this work Correspondence: Yingzhu Chen; Peipei Liu Email yzchendr@163.com; doclpp87@163.com The global spread of COVID-19 has caused a substantial societal burden and become a major global public health issue. The COVID-19 elderly population with hypertension, diabetes, cardiovascular, and cerebrovascular diseases are at risk. Mortality rates are highest in these individuals if infected with COVID-19. Although the lungs are the main organs involved in acute respiratory distress syndrome caused by COVID-19 infection, COVID-19 triggers inflammatory and immune mechanisms, inducing a "cytokine storm" that aggravates disease progression and may lead to death. Presently, effective drugs are lacking, although current studies have confirmed that drugs with therapeutic potential include redaciclovir, lopinavir/ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. Currently, the most reasonable and effective way to prevent COVID-19 is to control the source of infection, terminate routes of transmission, and protect susceptible populations. With the rise of COVID-19 in China and worldwide, further prevention, diagnosis, and treatment measures are a critical unmet need. Cerebrovascular disease has high incidence, disability rate, and fatality rate. COVID-19 patient outcomes may also be complicated with acute stroke. This paper summarizes the influence of COVID-19 on cerebrovascular disease and discusses possible pathophysiological mechanisms to provide new angles for the prevention and diagnosis of this disease. Keywords: novel coronavirus pneumonia, 2019-nCoV, SARS-CoV-2, cerebral vascular disease
psychiatry,clinical neurology